Metformin in Patients With Ulcerative Colitis Treated With Mesalamine

• Status: Not yet recruiting
• Trial end date: 2025-12-20
• Target enrollment: 0
• Participant gender: All

Summary

Ulcerative colitis (UC) is an idiopathic, chronic inflammatory disease characterized by diffused inflammation of the colon and rectum mucosa, however, the exact underlying mechanisms of UC remain poorly understood.UC is strongly dependent on cellular immune reaction and exaggerated inflammatory response due to genetic, immune and environmental factors.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Tanta University
• Treatments: Metformin

Criteria

Inclusion Criteria:

• Age ≥ 18 years

• Both males and females will be included

• Negative pregnancy test and effective contraception

Exclusion Criteria:

• •

• Breast feeding

• Significant liver and kidney function abnormalities

• Diabetic patients

• Colorectal cancer patients

• Patients with severe UC

• Patients taking rectal or systemic steroids

• Patients taking immunosuppressives or biological therapies

• Addiction to alcohol and / or drugs

• Known allergy to the studied medications